ResearchMoz

Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017

China Research and Intelligence Co., Ltd. (CRI)
Published Date » 2013-08-01
No. Of Pages » 50
In Chinese market, there are mainly three categories of invitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of invitro diagnostic reagent market in total in 2012. 

Global invitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global invitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets. 

In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprises concentrate in the biochemical reagent field, so the competition is mainly in the biochemical field. Both the supply and demand of immune and molecular products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises. Although China invitro diagnostic reagent industry started late and its scale is limited, it grows rapidly. In 2012, the market scale reached CNY 13.6 billion, among which immune diagnostic reagents, biochemical diagnostic reagents and molecular diagnostic reagents ranked among the top. 

According to the investigation of CRI, the production line utilization of various invitro diagnostic reagent manufacturers is universally high. Therefore, CRI predicts that the production capacity of the industry will expand in the future. Furthermore, the development strategy of most enterprises is transversely enriching product varieties and vertically developing towards the upstream and downstream. 

China's population accounts for more than 20% of the world's population, while the market share of invitro diagnostics is less than 5% of the world's; in 2012, the annual consumption per capita of China's invitro diagnostic products was less than USD 2, while that of developed countries reached USD 25 to USD 30. Therefore, there is a wide growth space for China's invitro diagnostics. CRI predicts that the growth rate of the market scale of China's invitro diagnostics will be markedly higher than the global average level and the CAGR will maintain over 15% from 2013 to 2017. By 2017, the market scale will reach CNY 30 billion, among which immune and biochemical products will continually occupy most of the market share, while the proportion of molecular products will relatively increase. During the upgrading of products in the future and the process of domestic substitution, the industry concentration rate will grow. 

Before 2003, medium and highend diagnostic products were monopolized by imports, but the improvement of domestic diagnostic reagent production levels has significantly changed the market pattern. In the primary market, the share of domestically made reagents is increasing gradually, while foreign enterprises still dominate the instrument market. Currently, Chinese domestic enterprises are gradually expanding from reagents to instruments and occupying the market through advantages of instruments to promote the sales of reagents. As diagnostic services are charged by project, medical institutions prefer cheaper domestically produced reagents as long as the quality is ensured. The costs saved can directly become revenue of the institutions. Currently, biochemical and enzyme immunoassay diagnostics continue to dominate the market of diagnostic reagents. 

Readers can obtain the following information or more through this report:

  • Status of Global and China Invitro Diagnostic Reagents
  • Governmental Policies on China Invitro Diagnostic Reagent Industry 
  • Status of Market Competition in Invitro Diagnostic Reagent Industry 
  • Major Invitro Diagnostic Reagent Manufacturers in Global and China Markets 
  • Forecast on the Development of Invitro Diagnostic Reagent Industry 

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Invitro Diagnostic Reagent Manufacturers 
  • Invitro Diagnostic Reagent Trading Enterprises 
  • Medical Institutions 
  • Research Institutions/Investors Concerned About Invitro Diagnostic Reagent Industry
Table of Content

Chapter 1 Overview on In-vitro Diagnostic Reagent Industry
1.1 Definition
1.2 Classification
1.2.1 Classification by Diagnosis Principles or Diagnosis Methods
1.2.2 China-featured Classification Methods
1.3 Industry Chain of In-vitro Diagnostic Reagents

Chapter 2 Global In-vitro Diagnostic Reagent Industry, 2011-2013
2.1 Industry Overview
2.1.1 Development Process
2.1.2 Competition Pattern
2.1. 3 Market Scale
2.2 Major Manufacturers of Global In-vitro Diagnostic Reagent Industry
2.2.1 F. Hoffmann-La Roche, Ltd.
2.2.2 Siemens AG
2.2.3 Abbott Laboratories

Chapter 3 Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2013
3.1 Economic Environment
3.2 Policy Environment
3.2.1 Competent Government Authorities
3.2.2 Policies on Enterprise Establishment
3.2.3 Policies on Production
3.2.4 Policies on Circulation

Chapter 4 Operation Status of China Diagnostic Reagent Industry, 2008-2012
4.1 Development Process of China In-vitro Diagnostic Reagent Industry16
4.2 Barriers to Entry
4.2.1 Policy Barriers
4. 2.2 Technological Barriers
4.2.3 Sales Channel Barriers
4.3 Supply Status of China In-vitro Diagnostic Reagent Industry
4.3.1 Major Manufacturers
4.3.2 Market Supply
4. 3. 3 Status of Market Competition
4.3.4 Status of Product Import and Export
4.4 Market Demand for In-vitro Diagnostic Reagents in China
4.4.1 Overall Market Scale
4.4.2 Market Scale of Biochemical Diagnostic Reagents
4.4.3 Market Scale of Immune Diagnostic Reagents
4.4.4 Market Scale of Molecular Diagnostic Reagents

Chapter 5 Top 5 Enterprises of China's In-vitro Diagnostic Reagent Industry, 2011-2013
5.1 Shanghai Kehua Bio-engineering Co., Ltd.
5.2 Shanghai Fosun Pharmaceutical Co., Ltd.
5.3 DAAN Gene Co., Ltd. of Sun Yat-sen University
5.4 Beijing Leadman Biochemistry Co., Ltd.
5.5 BioSino Bio-technology and Science Inc.

Chapter 6 Prospect of China In-vitro Diagnostic Reagent Industry, 2013-2017
6.1 Forecast on Supply
6.2 Forecast on Market Demand
6.2. 1 Industry Development Trend
6.2.2 Forecast on Overall Market Scale
6.2.3 Forecast on Segmented Market Scale
6.3 Forecast on Market Competition
6.3.1 Forecast on Popular Products
6.3.2 Forecast on Competition Pattern

List of Tables

NA

List of Figures


Chart Sales Value of Global Major In-vitro Diagnostics Enterprises, 2012 
Chart Market Scale of Global In-vitro Diagnostics Industry, 2007-2012 
Chart Market Distribution of Global In-vitro Diagnostics Industry, 2012
Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents Industry, 2013-2017
Chart Sales Value of In-vitro Diagnostics Products of Roche Diagnostics Department, 2008-2012 
Chart Major In-vitro Diagnostic Reagent Products of Roche on China Market
Chart Sales Value of In-vitro Diagnostics Products of Siemens Diagnostic Business Group, 2008-2012 
Chart Sales Value of In-vitro Diagnostics Products of Abbott Diagnostics Department, 2008-2012 
Chart Major Laws and Regulations on China's In-vitro Diagnostic Reagent Industry
Chart Major Manufacturers of In-vitro Diagnostic Reagents in China 
Chart Market Scale of China In-vitro Diagnostic Reagents, 2007-2012 
Chart Market Segmentation of China In-vitro Diagnostic Reagents, 2012 
Chart Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2007-2012 
Chart Market Scale of China Immune In-vitro Diagnostic Reagents, 2007-2012
Chart Market Scale of China Molecular In-vitro Diagnostic Reagents, 2007-2012 
Chart Major In-vitro Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd. 
Chart Sales Value of Diagnostic Reagent Products of Shanghai Kehua Bio-engineering Co., Ltd., 2008-2012 
Chart Diagnostic Reagent Product Structure of Shanghai Kehua Bio-engineering Co., Ltd., 2012-2013 
Chart Major In-vitro Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd. 
Chart Sales Value of Diagnostic Reagent Products of Beijing Leadman Biochemistry Co., Ltd., 2008-2012 
Chart Forecast on Market Scale of China In-vitro Diagnostic Reagents, 2013-2017 
Chart Forecast on Market Scale of China Biochemical In-vitro Diagnostic Reagents, 2013-2017 
Chart Forecast on Market Scale of China Immune In-vitro Diagnostic Reagents, 2013-2017 

Upcoming Reports:

Chilled Processed Food Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Chilled processed food market is expanding rapidly with the changing lifestyle of people all over the world. In today’s fast-paced world, chilled processed food will help in reducing the time spent on cooking, which will result in greater demand for quick meals. With better processing techniques and better quality offered, the chilled processed food market is gaining popularity in most growing economies.  Chilled Processed Food Market Segmentation  Product segmentation of chilled processed food market is as follows: Processed Red...
Coxsackievirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Coxsackieviruses are non-enveloped viruses belonging to the picornaviridae family and enterovirus genus that possess linear single-stranded RNA as their genetic material. Based on their pathogenecity tested on mice, they are further categorized into group A and group B viruses. Group A viruses are known to cause skin and mucous membrane infections leading to disorders such as herpangina, hand-foot-and-mouth (HFM) disease and acute hemorrhagic conjunctivitis (AHC), whereas, group B viruses infect the pancreas, liver and heart leading to various conditions such as pericarditis,...
Video Analytics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
Video analytics holds great promise, enabling enhanced security and surveillance solutions by automatically monitoring video with specific objective. Video analytic system can provide real time alarms based on defined rules without the need for human interface. This enhances operation effectiveness by working 24/7, reducing the amount of video data to be reviewed by human operators, and thus enabling a high level accuracy of video monitoring. Technological trends such as the growing performance of cloud computing is directing the video analytics market. Technological...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...